"Tau oligomers," what we know and what we don't know

Frontiers in Neurology

Volumn 5 JAN, Issue , 2014, Pages

  Sahara, Naruhiko ^a   Avila, Jesus ^b  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

Neurodegenerative disease; Propagation; Tau phosphorylation; Tau protein; Tauopathy

Indexed keywords

OLIGOMER; TAU OLIGOMER; TAU PROTEIN; UNCLASSIFIED DRUG;

DISULFIDE BOND; EDITORIAL; NEUROPATHOLOGY; NEUROTOXICITY; OLIGOMERIZATION; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; TAUOPATHY; THERMOSTABILITY;

EID: 84893500823     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2014.00001     Document Type: Editorial

References (12)

1. Gerson JE, Kayed R. Formation and propagation of tau oligomeric seeds. Front Neurol (2013) 4:93. doi: 10.3389/fneur.2013.00093.
2. Cowan CM, Mudher A. Are tau aggregates toxic or protective in tauopathies? Front Neurol (2013) 4:114. doi:10.3389/fneur.2013.00114.
3. Ren Y, Sahara N. Characteristics of tau oligomers. Front Neurol (2013) 4:102. doi:10.3389/fneur.2013.00102.
4. Guzman-Martinez L, Farias GA, Maccioni RB. Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs. Front Neurol (2013) 4:167. doi:10.3389/fneur.2013.00167.
5. Götz J, Xia D, Leinenga G, Chew YL, Nicholas H. What renders tau toxic. Front Neurol (2013) 4:72. doi:10.3389/fneur.2013.00072.
6. Gendreau KL, Hall GF. Tangles, toxicity, and tau secretion in AD-new approaches to a vexing problem. Front Neurol (2013) 4:160. doi:10.3389/fneur.2013.00160.
7. Mattei TA. Is it all about contact? Neurodegeneration as a "protein freeze tag game" inside the central nervous system. Front Neurol (2013) 4:75. doi:10.3389/fneur.2013.00075.
8. Simon D, Hernandez F, Avila J. The involvement of cholinergic neurons in the spreading of tau pathology. Front Neurol (2013) 4:74. doi:10.3389/fneur.2013.00074.
9. Noble W, Hanger DP, Miller CCJ, Lovestone S. The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol (2013) 4:83. doi:10.3389/fneur.2013.00083.
10. Leugers CJ, Koh JY, Hong W, Lee G. Tau in MAPK activation. Front Neurol (2013) 4:161. doi:10.3389/fneur.2013.00161.
11. Iqbal K, Gong CX, Liu F. Hyperphosphorylation-induced tau oligomers. Front Neurol (2013) 4:112. doi:10.3389/fneur.2013.00112.
12. Chesser AS, Pritchard SM, Johnson GVW. Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease. Front Neurol (2013) 4:122. doi:10.3389/fneur.2013.00122.